Price transparency stumbled out of the gate last week as hospitals complied with a new CMS requirement to publish their retail charges online for individual services and diagnosis-related groups.
Category: Modern Healthcare
Do digital tools fail to show impact in high-risk, high-cost populations?
The top-funded private digital health companies in the U.S. tended to look at healthy populations in their studies published in peer-reviewed journals.
Indian Health Service urban programs threatened by government shutdown
Some Indian Health Service urban health programs are close to running out of money as the partial government shutdown enters week three.
Not-for-profits win after court’s ruling on 340B cuts
Not-for-profit hospitals in the 340B program stand to benefit the most after a federal judge blocked a proposal to cut reimbursement in the drug discount program by 30%.
NYC H&H consolidating six administrative offices
The largest public health system in the country will relocate about 2,600 employees to 14 stories of the revamped building at 50 Water St. in Manhattan over five years.
Coding changes driving reductions in readmission rates
A new study in Health Affairs found that changes in coding practices among hospitals influenced reported decreases in readmissions rates.
On the ground at J.P. Morgan’s Health Conference
The J.P. Morgan Healthcare Conference kicked off in San Francisco on Monday. Tara Bannow provides a snapshot of the news of the day, including Advocate Aurora Health’s presentation.
Eli Lilly to spend about $8B on Loxo Oncology
Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities.
Drugmakers seek sanctions over ’60 Minutes’ comments
Several drug manufacturers targeted in lawsuits over the opioid epidemic claim statements made by Ohio’s attorney general and governor-elect and two other lawyers on an episode of CBS’ “60 Minutes” were calculated to taint potential jury pools.
Generic drug initiative Civica Rx welcomes 12 new members
The Utah-based not-for-profit generic-drug company, Civica Rx, represents the frustration of the numerous hospitals that must work around persistent shortages of simple but vital drugs.
